These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 79625)

  • 21. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
    Shigeta S; Mori S; Baba M; Ito M; Honzumi K; Nakamura K; Oshitani H; Numazaki Y; Matsuda A; Obara T
    Antimicrob Agents Chemother; 1992 Feb; 36(2):435-9. PubMed ID: 1605607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.
    Hosoya M; Mori S; Tomoda A; Mori K; Sawaishi Y; Kimura H; Shigeta S; Suzuki H
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4631-5. PubMed ID: 15561836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ribavirin on murine cytomegalovirus infection.
    Dowling JN; Postic B; Guevarra LO
    Antimicrob Agents Chemother; 1976 Nov; 10(5):809-13. PubMed ID: 188383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of ribovirine (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboximide) on RNA-dependent RNA-polymerase induction and virus-specific polysome formation in cell cultures infected with influenza A virus].
    Linitskaia GL; Iatsyna AA; Pushkarskaia NL; Galegov GA
    Vopr Med Khim; 1978; 24(5):699-702. PubMed ID: 568351
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiviral effects if ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine against dengue viruses in vitro.
    Koff WC; Elm JL; Halstead SB
    Antiviral Res; 1982 May; 2(1-2):69-79. PubMed ID: 7201778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ribavirin on the replication of infectious pancreatic necrosis virus in fish cell cultures.
    Migus DO; Dobos P
    J Gen Virol; 1980 Mar; 47(1):47-57. PubMed ID: 7365468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic expression of antigen and infectious virus in a BHK cell line (0-853) persistently infected with an SSPE strain of measles virus.
    Cremer NE; Oshiro LS; Hagens SJ
    J Gen Virol; 1979 Mar; 42(3):637-40. PubMed ID: 372496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.
    Wyde PR; Moore-Poveda DK; De Clercq E; Neyts J; Matsuda A; Minakawa N; Guzman E; Gilbert BE
    Antimicrob Agents Chemother; 2000 May; 44(5):1146-52. PubMed ID: 10770743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin).
    Oxford JS
    J Gen Virol; 1975 Sep; 28(3):409-14. PubMed ID: 1176969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis.
    Hashimoto K; Hosoya M
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.
    Hall WW; Lamb RA; Choppin PW
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2047-51. PubMed ID: 287042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.
    Streeter DG; Witkowski JT; Khare GP; Sidwell RW; Bauer RJ; Robins RK; Simon LN
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1174-8. PubMed ID: 4197928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral efficacy of pyrazofurin against selected RNA viruses.
    Canonico PG; Jahrling PB; Pannier WL
    Antiviral Res; 1982 Dec; 2(6):331-7. PubMed ID: 6299188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus.
    Paragas J; Whitehouse CA; Endy TP; Bray M
    Antiviral Res; 2004 Apr; 62(1):21-5. PubMed ID: 15026198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of measles virus replication and enhancement of cellular DNA synthesis in vero cells by ribavirin, an antiviral and antineoplastic drug.
    Chill DW; Johnston PB
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Jun; 8(2):67-72. PubMed ID: 1243121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ribavirin on respiratory syncytial virus in vitro.
    Hruska JF; Bernstein JM; Douglas RG; Hall CB
    Antimicrob Agents Chemother; 1980 May; 17(5):770-5. PubMed ID: 7396465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the inhibition of plant virus multiplication by ribavirin.
    Lerch B
    Antiviral Res; 1987 Jun; 7(5):257-70. PubMed ID: 2821895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribavirin inhibits mast cell mediator release.
    Marquardt DL; Gruber HE; Walker LL
    J Pharmacol Exp Ther; 1987 Jan; 240(1):145-9. PubMed ID: 2949069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy and prognosis in subacute sclerosing panencephalitis].
    Hosoya M
    Nihon Rinsho; 2007 Aug; 65(8):1483-6. PubMed ID: 17695288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.